Autophagy Inhibitors

Cat.No. Product Name Information Product Use Citations Product Validations
S6999 Chloroquine Chloroquine is an antimalarial drug and autophagy/lysosome inhibitor. Chloroquine also suppresses Toll-like receptor-9 (TLR9) protein expression. Chloroquine is highly effective agianst SARS-CoV-2 (COVID-19) infection with EC50 of 1.13 μM in Vero E6 cells. Chloroquine has anti-HIV-1 activity.
Signal Transduct Target Ther, 2025, 10(1):26
Cell Discov, 2025, 11(1):15
Cell Metab, 2025, S1550-4131(25)00149-4
S4157 Chloroquine diphosphate Chloroquine diphosphate is a 4-aminoquinoline anti-malarial and anti-rheumatoid agent, also acting as an ATM activator. Chloroquine is also an inhibitor of toll-like receptors (TLRs).
Front Vet Sci, 2025, 12:1587391
Nat Commun, 2024, 15(1):1642
Cancer Lett, 2024, 604:217258
Verified customer review of Chloroquine diphosphate
S4430 HCQ (Hydroxychloroquine) Sulfate Hydroxychloroquine (HCQ) Sulfate is an antimalarial agent used for the treatment of systemic lupus erythematosus, rheumatoid arthritis and other autoimmune, inflammatory and dermatologic conditions. Also acts as an inhibitor of autophagy and toll-like receptor (TLR) 7/9.
EMBO J, 2025, 10.1038/s44318-025-00581-3
iScience, 2025, 28(4):112054
Int J Mol Sci, 2025, 26(2)588
Verified customer review of HCQ (Hydroxychloroquine) Sulfate
S7888 Spautin-1 Spautin-1 is a potent and specific autophagy inhibitor, and inhibits the deubiquitinating activity of USP10 and USP13 with IC50 of ∼0.6-0.7 μM. This compound enhances apoptosis.
Life Science Alliance, September 27, 2021, e202101137
Scientific Reports, July 07, 2022, 11533
OncoImmunology, February 15, 2018, e1431086
Verified customer review of Spautin-1
S7683 PIK-III PIK-III (VPS34-IN2), which is a selective inhibitor of ​VPS34 enzymatic activity, inhibits autophagy and de novo lipidation of LC3 and leads to the stabilization of autophagy substrates. The IC50 values for VPS34 and PI(3)Kδ are 0.018 μM and 1.2 μM respectively.
Cell Res, 2025, 10.1038/s41422-025-01085-9
Cell Rep, 2024, 43(1):113575
Sci Rep, 2024, 14(1):4000
Verified customer review of PIK-III
S8369 Lys05 Trihydrochloride Lys05 is a new lysosomal autophagy inhibitor which potently accumulates within and deacidifies the lysosome of both cells and tumors, resulting in sustained inhibition of autophagy and tumor growth.
Blood, October 20, 2024, Online ahead of print
bioRxiv, November 28, 2023, nan
Oncotarget, August 29, 2024, 16:681-696
S8808 DC661 DC661 is a potent palmitoyl protein thioesterase 1 (PPT1) inhibitor. DC661 is capable of deacidifying the lysosome and inhibiting autophagy significantly better than HCQ. DC661 induces apoptosis.
Cell Signal, 2025, 134:111879
Autophagy, 2024, 1-13.
Cell Mol Life Sci, 2024, 82(1):27
E4824 Hydroxychloroquine Hydroxychloroquine (HCQ) is an antimalarial drug that inhibits autophagy and is used to treat systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). It exhibits immunomodulatory, antithrombotic, and antiplatelet properties. It inhibits the release endothelin-1, a potent vasoconstrictor, and restores impaired angiogenesis in TNF-α-treated endothelial cells in vitro. It also reduces the production of inflammatory cytokines such as TNF-α, IFN-γ, and IL-6 from peripheral blood mononuclear cells, upregulates IL-10 and decreases platelet aggregation.
Journal of Cancer, October 17, 2017, 3774-3784
International Journal of Oncology, March 24, 2017, 1810-1820
PLoS One, June 28, 2021, e0251731
S8596 Autophinib Autophinib is a potent autophagy inhibitor with a novel chemotype with IC50 values of 90 and 40 nM for autophagy in starvation induced autophagy assay and rapamycin induced autophagy assay. The IC50 value for Vps34 is 19 nM in vitro.
Cancer Commun (Lond), 2024, 44(3):408-432
Burns Trauma, 2024, 12:tkad057
Phytomedicine, 2023, 10.1016/j.phymed.2023.155090
S6716 NSC 185058 NSC185058 inhibits ATG4B, the lipidation of LC3B, and autophagy without affecting the MTOR or PtdIns3K pathways.
STAR Protocols, 2024, 103181
STAR Protoc, 2024, 5(3):103181
Autophagy, 2023, 2275-2295
S3698 Nortriptyline hydrochloride Nortriptyline hydrochloride (Desitriptyline, ELF-101, EN-7048, Desmethylamitriptyline) is the hydrochloride salt form of nortriptyline, a tricyclic antidepressant agent used for short-term treatment of various forms of depression.
Frontiers in Bioinformatics, September 14, 2021, 710591
EMBO Molecular Medicine, December 23, 2025, 433-461
EMBO Molecular Medicine, December 23, 2025, Epub ahead of print
S8527 ROC-325 ROC-325 is an orally available novel inhibitor of lysosomal-mediated autophagy which diminishes AML cell viability with the IC50 range of 0.7-2.2 μM.
eLife, March 28, 2023, e83205
Frontiers in Pharmacology, February 5, 2024, 1344075
Front Pharmacol, 2024, 15:1344075
S8576 EAD1 EAD1 is a potent autophagy inhibitor with an IC50 of 5.8 μM in the BxPC3 cells. It has antiproliferative activities in lung and pancreatic cancer cells.
Mol Cancer Ther, 2022, 21(1):79-88
Autophagy, 2021, 1-17
S5920 CA-5f CA-5f is a potent late-stage macroautophagy/autophagy inhibitor via inhibiting autophagosome-lysosome fusion.
Journal of Virology, 2022, e01550-21
Journal of Virology, 2022, e0155021
Journal of Virology, 2021, e01550-21
S9150 Daurisoline Daurisoline, a bis-benzylisoquinoline alkaloid isolated from the rhizomes of Menispermum dauricum, is a potent autophagy blockers with antiarrhythmic effects.
Biochem Pharmacol, 2024, 223:116113
Cell Death Dis, 2022, 13(11):1000
S8764 IITZ-01 IITZ-01 is a potent autophagy inhibitor, enhancing autophagosome accumulation but inhibiting autophagosomal degradation by impairing lysosomal function.
Cancers (Basel), 2020, 12(9):E2363
S9424 Liensinine diperchlorate Liensinine, a major isoquinoline alkaloid, inhibits late-stage autophagy/mitophagy through blocking autophagosome-lysosome fusion. It is a novel autophagy/mitophagy inhibitor.
Molecular Therapy, 2023, 174-192
S6471 Lucanthone Lucanthone is a novel autophagic inhibitor and also an orally available thioxanthone-based DNA intercalator and inhibitor of the DNA repair enzyme apurinic-apyrimidinic endonuclease 1.
International Journal of Molecular Sciences, 2021, 17
Int J Mol Sci, 2021, 23(1)17
E4809 Piperaquine tetraphosphate tetrahydrate Piperaquine tetraphosphate tetrahydrate is an inhibitor of autophagy . It is a bisquinoline antimalarial agent effective against Plasmodium falciparum. This compound is useful in antimalarial research.
E8307New Chloroquine dihydrochloride Chloroquine dihydrochloride acts as an inhibitor of autophagy and toll-like receptors (TLRs). Chloroquine dihydrochloride is an antimalarial and anti-inflammatory agent widely used to treat malaria and rheumatoid arthritis.
E6578New AS1708727 AS1708727 is an orally bioavailable Foxo1 inhibitor that exhibits EC50 values of 0.33 μM against G6Pase and 0.59 μM against PEPCK.
S8744 PHY34 PHY34 is a late-stage autophagy inhibitor with nanomolar potency and significant antitumor efficacy as a single agent against HGSOC in vivo.
S1105 LY294002 LY294002 (SF 1101, NSC 697286) is the first synthetic molecule known to inhibit PI3Kα/δ/β with IC50 of 0.5 μM/0.57 μM/0.97 μM, respectively; more stable in solution than Wortmannin, and also blocks autophagosome formation. It not only binds to class I PI3Ks and other PI3K-related kinases, but also to novel targets seemingly unrelated to the PI3K family. This compound also inhibits CK2 with IC50 of 98 nM. It is a non-specific DNA-PKcs inhibitor and activates autophagy and apoptosis.
Gut, 2025, gutjnl-2025-335163
Cell Mol Immunol, 2025, 22(5):541-556
Nat Commun, 2025, 16(1):1661
Verified customer review of LY294002
S1013 Bortezomib Bortezomib is a potent 20S proteasome inhibitor with Ki of 0.6 nM. It exhibits favorable selectivity towards tumor cells over normal cells. This compound inhibits NF-κB and induces ERK phosphorylation to suppress cathepsin B and inhibit the catalytic process of autophagy in ovarian cancer and other solid tumors.
J Proteomics, 2026, 322:105536
Signal Transduct Target Ther, 2025, 10(1):81
Cell Host Microbe, 2025, 33(4):512-528.e7
Verified customer review of Bortezomib
S1460 SP600125 SP600125 (Nsc75890) is a broad-spectrum JNK inhibitor for JNK1, JNK2 and JNK3 with IC50 of 40 nM, 40 nM and 90 nM in cell-free assays, respectively; 10-fold greater selectivity against MKK4, 25-fold greater selectivity against MKK3, MKK6, PKB, and PKCα, and 100-fold selectivity against ERK2, p38, Chk1, EGFR etc. This compound is also a broad‐spectrum inhibitor of serine/threonine kinases including Aurora kinase AFLT3 and TRKA with of IC50 of 60 nM, 90 nM and 70 nM. It inhibits autophagy and activates apoptosis.
Nat Commun, 2025, 16(1):7156
Adv Sci (Weinh), 2025, 12(28):e2502634
Adv Sci (Weinh), 2025, 12(36):e00028
Verified customer review of SP600125
S2767 3-Methyladenine (3-MA) 3-Methyladenine (3-MA) is a selective PI3K inhibitor for Vps34 and PI3Kγ with IC50 of 25 μM and 60 μM in HeLa cells. It blocks class I PI3K consistently, whereas suppression of class III PI3K is transient, and also inhibits autophagosome formation. Solutions are unstable and should be fresh-prepared.
Life Science Alliance, March 25, 2024, e202302408
Scientific Reports, December 5, 2025, 31141
BMC Gastroenterology, August 1, 2024, 245
Verified customer review of 3-Methyladenine (3-MA)
S1102 U0126-EtOH U0126-EtOH is a highly selective inhibitor of MEK1/2 with IC50 of 0.07 μM/0.06 μM in cell-free assays, 100-fold higher affinity for ΔN3-S218E/S222D MEK than PD98059. U0126 inhibits autophagy and mitophagy with antiviral activity.
Nat Commun, 2025, 16(1):2192
Nat Commun, 2025, 16(1):7156
Adv Sci (Weinh), 2025, 12(44):e11726
Verified customer review of U0126-EtOH
S1413 Bafilomycin A1 (Baf-A1) Bafilomycin A1 (Baf-A1) is a vacuolar H+-ATPase inhibitor with IC50 of 0.44 nM, and it is found to inhibit autophagy while inducing apoptosis.
Cell & Bioscience, July 05, 2025, 96
Journal of Cellular and Molecular Medicine, February 28, 2021, 3348-3360
Cells, August 09, 2025, 1231
Verified customer review of Bafilomycin A1 (Baf-A1)
S1150 Paclitaxel Paclitaxel is a microtubule polymer stabilizer with IC50 of 0.1 pM in human endothelial cells.Paclitaxel can cause both mitotic arrest and apoptotic cell death. Paclitaxel also induces autophagy.
Cancer Research, March 01, 2021, 1413-1425
International Journal of Molecular Medicine, February 01, 2019, 1866-1878
Therapeutic Advances in Medical Oncology, December 11, 2024, 17588359241303302
Verified customer review of Paclitaxel
S1092 KU-55933 KU-55933 is a potent and specific ATM inhibitor with IC50/Ki of 12.9 nM/2.2 nM in cell-free assays, and is highly selective for ATM as compared to DNA-PK, PI3K/PI4K, ATR and mTOR. KU‑55933 (ATM Kinase Inhibitor) inhibits the activation of autophagy‑initiating kinase ULK1 and results in a significant decrease of autophagy.
Proc Natl Acad Sci U S A, November 30, 2021, e2103585118
Oncology Reports, March 13, 2018, 2071-2080
PLoS One, July 30, 2015, e0134411
Verified customer review of KU-55933
S2758 Wortmannin (SL-2052) Wortmannin is the first described PI3K inhibitor with IC50 of 3 nM in a cell-free assay, with little selectivity within the PI3K family. Wortmannin blocks autophagosome formation and potently inhibits DNA-PK/ATM with IC50 of 16 nM and 150 nM in cell-free assays. Wortmannin also inhibits PLK1 activity.
Nat Commun, 2025, 16(1):1313
EMBO J, 2025, 10.1038/s44318-025-00507-z
EMBO Mol Med, 2025, 10.1038/s44321-025-00222-6
Verified customer review of Wortmannin (SL-2052)
S8037 Necrostatin-1 (Nec-1) Necrostatin-1 (Nec-1) is a specific RIP1 (RIPK1) inhibitor and inhibits TNF-α-induced necroptosis with EC50 of 490 nM in 293T cells. Necrostatin-1 also blocks IDO and suppresses autophagy and apoptosis.
Cell Res, 2025, 10.1038/s41422-025-01167-8
Signal Transduct Target Ther, 2025, 10(1):341
Cancer Discov, 2025, 10.1158/2159-8290.CD-24-1317
Verified customer review of Necrostatin-1 (Nec-1)
S1109 BI 2536 BI-2536 is a potent Plk1 inhibitor with IC50 of 0.83 nM in a cell-free assay. BI-2536 inhibits Bromodomain 4 (BRD4) with Kd of 37 nM and potently suppresses c-Myc expression. BI-2536 induces apoptosis and attenuates autophagy. Phase 2.
Gut, 2025, gutjnl-2024-334274
Nat Commun, 2025, 16(1):1599
Genome Biol, 2025, 26(1):204
Verified customer review of BI 2536
S1490 Ponatinib (AP24534) Ponatinib is a novel, potent multi-target inhibitor of Abl, PDGFRα, VEGFR2, FGFR1 and Src with IC50 of 0.37 nM, 1.1 nM, 1.5 nM, 2.2 nM and 5.4 nM in cell-free assays, respectively. Ponatinib (AP24534) inhibits autophagy.
Nat Commun, 2025, 16(1):471
Theranostics, 2025, 15(8):3589-3609
J Exp Clin Cancer Res, 2025, 44(1):290
Verified customer review of Ponatinib (AP24534)
S1786 Verteporfin Verteporfin is a small molecule that inhibits TEAD–YAP association and YAP-induced liver overgrowth. It is also a potent second-generation photosensitizing agent derived from porphyrin. Verteporfin is an autophagy inhibitor. Verteporfin inhibits cell proliferation and induces apoptosis.
Theranostics, 2026 Jan 1, 2372-2387
Theranostics, 2026, 2372-2387
Pharmaceutics, 2025 Mar 28, 434
Verified customer review of Verteporfin
S2704 LY2109761 LY2109761 is a novel selective TGF-β receptor type I/II (TβRI/II) dual inhibitor with Ki of 38 nM and 300 nM in a cell-free assay, respectively; shown to negatively affect the phosphorylation of Smad2. This compound blocks autophagy and induces apoptosis.
Cancer Res, 2025, 10.1158/0008-5472.CAN-25-3425
Research (Wash D C), 2025, 8:1002
J Nanobiotechnology, 2025, 23(1):748
Verified customer review of LY2109761
S2775 Nocodazole Nocodazole is a rapidly-reversible inhibitor of microtubule polymerization, also inhibits Abl, Abl(E255K) and Abl(T315I) with IC50 of 0.21 μM, 0.53 μM and 0.64 μM in cell-free assays, respectively. Nocodazole induces apoptosis.
Adv Mater, 2025, e17493.
Nat Commun, 2025, 16(1):7898
EMBO J, 2025, 44(22):6556-6597
Verified customer review of Nocodazole
S1113 GSK690693 GSK690693 is a pan-Akt inhibitor targeting Akt1/2/3 with IC50 of 2 nM/13 nM/9 nM in cell-free assays, also sensitive to the AGC kinase family: PKA, PrkX and PKC isozymes. GSK690693 also potently inhibits AMPK and DAPK3 from the CAMK family with IC50 of 50 nM and 81 nM, respectively. GSK690693 affects Unc-51-like autophagy activating kinase 1 (ULK1) activity, robustly inhibits STING-dependent IRF3 activation. Phase 1.
Theranostics, 2025, 15(18):9819-9837
Cell Rep, 2025, 44(7):115947
Front Cell Infect Microbiol, 2025, 15:1543186
Verified customer review of GSK690693
S7811 MHY1485 MHY1485 is a potent, and cell-permeable mTOR activator, and this compound also potently inhibits autophagy.
Research (Wash D C), 2025, 8:1002
Front Immunol, 2025, 16:1643676
Biol Res, 2025, 58(1):67
Verified customer review of MHY1485
S7046 Brefeldin A (BFA chemical) Brefeldin A (BFA) is a lactone antibiotic and ATPase inhibitor for protein transport with IC50 of 0.2 μM in HCT 116 cells, induces cancer cell differentiation and apoptosis. It could also improve the HDR(homology-directed repair) efficiency and be an enhancer of CRISPR-mediated HDR. Brefeldin A is also an inhibitor of autophagy and mitophagy.
Protein Cell, 2025, pwaf020
Cancer Commun (Lond), 2025, 10.1002/cac2.70036
J Integr Plant Biol, 2025, 67(8):2229-2244
Verified customer review of Brefeldin A (BFA chemical)
S7455 Resatorvid (TAK-242) Resatorvid (TAK-242, CLI-095) is a small-molecule-specific inhibitor of Toll-like receptor (TLR) 4 signaling, blocking LPS-induced production of NO, TNF-α and IL-6 in macrophages with IC50 of 1.8 nM, 1.9 nM and 1.3 nM, respectively. This compound downregulates expression of TLR4 downstream signaling molecules MyD88 and TRIF, and it also inhibits autophagy.
EMBO J, 2025, 10.1038/s44318-025-00515-z
Carbohydr Polym, 2025, 350:122980
J Neuroinflammation, 2025, 22(1):38
S3042 Purmorphamine Purmorphamine (Shh Signaling Antagonist VI), which directly binds and activates Smoothened, blocks BODIPY-cyclopamine binding to Smo with IC50 of ~ 1.5 μM in HEK293T cell and also is an inducer of osteoblast differentiation with EC50 of 1 μM. Purmorphamine can reduce both basal and induced autophagy.
Nat Commun, 2025, 16(1):8693
Commun Biol, 2025, 8(1):1177
Development, 2025, 152(3)DEV204214
Verified customer review of Purmorphamine
S7146 DMH1 DMH1 is a selective BMP receptor inhibitor with IC50 of 107.9 nM for ALK2, exhibiting no inhibition on AMPK, ALK5, KDR (VEGFR-2) or PDGFR. This compound inhibits autophagy.
Cell Stem Cell, 2025, S1934-5909(25)00081-5
Nat Commun, 2025, 16(1):10435
J Adv Res, 2025, S2090-1232(25)00553-3
Verified customer review of DMH1
S7751 VER-155008 VER155008 is a potent Hsp70 family inhibitor with IC50 of 0.5 μM, 2.6 μM, and 2.6 μM in cell-free assays for HSP70, HSC70, and GRP78 (HSPA5, Bip), respectively, >100-fold selectivity over HSP90. VER155008 inhibits autophagy and causes reduced levels of HSP90 client proteins.
Nat Cell Biol, 2025, 27(9):1448-1464
Biomolecules, 2025, 15(1)76
J Microbiol Biotechnol, 2025, 35:e2508015
Verified customer review of VER-155008
S7423 KN-93 Phosphate KN-93 Phosphate is a potent and specific inhibitor of Ca2+/calmodulin-dependent protein kinase II (CaMKII) with Ki of 0.37 μM, no remarkable inhibitory effects on APK, PKC, MLCK or Ca2+-PDE activities. KN-93 attenuates CaMKII-induced autophagy.This product is not soluble in saline. Please do not dissolve it in saline for administration.
Stem Cell Res Ther, 2025, 16(1):208
bioRxiv, 2025, 2025.03.20.644192
Eye Vis (Lond), 2024, 11(1):37
Verified customer review of KN-93 Phosphate
S7033 GSK2656157 GSK2656157 is an ATP-competitive and highly selective inhibitor of PERK with IC50 of 0.9 nM in a cell-free assay, 500-fold greater against a panel of 300 kinases. This compound decreases apoptosis and inhibits excessive autophagy.
EMBO J, 2025, 44(4):1107-1130
J Adv Res, 2025, S2090-1232(25)00385-6
J Clin Invest, 2024, 135(1)e179874
Verified customer review of GSK2656157
S2243 Degrasyn (WP1130) Degrasyn (WP1130) is a selective deubiquitinase (DUB: USP5, UCH-L1, USP9x, USP14, and UCH37) inhibitor and also suppresses Bcr/Abl, also a JAK2 transducer (without affecting 20S proteasome) and activator of transcription (STAT). This compound induces apoptosis and blocks autophagy.
Nat Commun, 2025, 16(1):628
Nat Commun, 2025, 16(1):1313
Cell Death Dis, 2025, 16(1):564
Verified customer review of Degrasyn (WP1130)
S7949 MRT68921 Hydrochloride MRT68921 is a potent and dual autophagy kinase ULK1/2 inhibitor with IC50 of 2.9 nM and 1.1 nM, respectively.
Autophagy, 2025, 1-20.
Theranostics, 2025, 15(1):258-276
EMBO Mol Med, 2025, 17(12):3472-3495
Verified customer review of MRT68921 Hydrochloride
S8222 AS1842856 AS1842856 is a cell-permeable inhibitor that blocks the transcription activity of Foxo1 with IC50 of 33 nM. It could directly bind to the active Foxo1, but not the Ser256-phosphorylated form. AS1842856 suppresses autophagy.
Environ Int, 2025, 205:109862
Int Immunopharmacol, 2025, 162:115128
J Mol Cell Biol, 2025, mjaf021
Verified customer review of AS1842856
S7682 SAR405 SAR405 is a low-molecular-mass kinase inhibitor of PIK3C3/Vps34 (KD 1.5 nM) showing high selectivity and not be active up to 10 μM on class I and class II PI3Ks as well as on mTOR. SAR405 prevents autophagy and synergizes with MTOR (mechanistic target of rapamycin) inhibition in tumor cells.
Cell Res, 2025, 10.1038/s41422-025-01085-9
Nat Cell Biol, 2025, 27(9):1448-1464
Autophagy, 2025, 21(7):1523-1543
Verified customer review of SAR405
S7885 SBI-0206965 SBI-0206965 is a highly selective autophagy kinase ULK1 inhibitor with IC50 of 108 nM, about 7-fold selectivity over ULK2. SBI-0206965 inhibits autophagy and enhances apoptosis in human glioblastoma and lung cancer cells.
Cell Res, 2025, 10.1038/s41422-025-01085-9
Theranostics, 2025, 15(1):258-276
Cell, 2024, 187(15):4043-4060.e30
Verified customer review of SBI-0206965
S7381 Pepstatin A Pepstatin A (Pepstatin) is a potent aspartic protease inhibitor, and also inhibits HIV replication. Pepstatin A is also an inhibitor of cathepsins D and cathepsins E. Pepstatin A inhibits autophagy by suppressing lysosomal proteases.
Nat Commun, 2025, 16(1):4069
Autophagy, 2025, 21(11):2473-2496
J Exp Clin Cancer Res, 2025, 44(1):317
S1346 Heparin Sodium Heparin sodium, a sulfated polysaccharide belonging to the family of glycosaminoglycans, has numerous important biological activities associated with its interaction with diverse proteins. Heparin is used as an anticoagulant primarily through its interaction with AT III by enhancing AT-IIImediated inhibition of blood coagulation factors, including thrombin and factor Xa. Heparin prevents the induction of autophagy.
Communications Biology, September 02, 2022, 902
Nature Communications, November 12, 2024, 9771
Stem Cells Translational Medicine, May 27, 2022, 552-565
S7289 PFK-015 PFK15 (PFK-015) is a potent and selective 6-phosphofructo-2-kinase (PFKFB3) inhibitor with IC50 of 207 nM.
Nature, 2025, 10.1038/s41586-025-09328-w
Adv Healthc Mater, 2025, e2501417.
Cell Commun Signal, 2025, 23(1):104
Verified customer review of PFK-015
S1835 Azithromycin Azithromycin is an antibiotic by inhibiting protein synthesis, used for the treatment of bacterial infections.
Commun Biol, 2025, 8(1):1261
Nat Commun, 2024, 15(1):6579
Int Immunopharmacol, 2024, 137:112426
S2930 Pifithrin-μ Pifithrin-μ (NSC 303580, PFTμ, 2-Phenylethynesulfonamide) is a specific p53 inhibitor by reducing its affinity to Bcl-xL and Bcl-2, and this compound also inhibits HSP70 function and autophagy.
Cell Death Dis, 2025, 16(1):42
Front Nutr, 2025, 12:1663245
Sci Adv, 2025, 11(12):eadq9111
Verified customer review of Pifithrin-μ
S8274 STO-609 STO-609 is a specific inhibitor of the Ca2+/Calmodulin-dependent protein kinase kinase(CaM-KK) that inhibits the activities of recombinant CaM-KKα and CaM-KKβ isoforms, with Ki values of 80 and 15 ng/ml, respectively, and also inhibits their autophosphorylation activities. This compound inhibits AMPKK activity and inhibits autophagy.
Redox Rep, 2025, 30(1):2447721
PLoS One, 2025, 20(8):e0330282
Cell Genom, 2025, 5(3):100782
S7660 Obeticholic Acid (INT-747) Obeticholic Acid (INT-747) is a potent and selective farnesoid X receptor (FXR) agonist with EC50 of 99 nM, and it inhibits autophagy. This compound is in Phase 3.
Nat Commun, 2025, 16(1):2093
Cell Commun Signal, 2025, 23(1):236
Am J Physiol Gastrointest Liver Physiol, 2025, 328(5):G558-G577
Verified customer review of Obeticholic Acid (INT-747)
S7948 MRT67307 HCl MRT67307 is a potent and dual IKKϵ and TBK1 inhibitor with IC50 of 160 and 19 nM, respectively. MRT67307 potently inhibits ULK1 and ULK2 and blocks autophagy.
EMBO Rep, 2025, 10.1038/s44319-025-00444-2
EMBO J, 2024, 10.1038/s44318-024-00244-9
mBio, 2023, 10.1128/mbio.02506-23
Verified customer review of MRT67307 HCl
S8793 ULK-101 ULK-101 is a potent and selective ULK1 inhibitor with IC50 values of 8.3 nM and 30 nM for ULK1 and ULK2, respectively.
Theranostics, 2025, 15(1):258-276
Immunity, 2024, 57(2):287-302.e12
Cell Rep, 2024, 43(1):113575
S8317 3BDO 3BDO, a butyrolactone derivative, could target FKBP1A and activate the mTOR signaling pathway. It inhibits autophagy in HUVECs. This compound inhibits oxLDL-induced apoptosis.
Cancer Immunology Research, May 02 2024, 631-643
Journal of Neuroscience, July 15 2020, 5531-5548
Cancer Immunology Research, 2024, 631–643
S8807 PFK158 PFK158 is a potent and selective inhibitor of PFKFB3. It has improved PK properties and causes ~80% growth inhibition in several mouse models of human-derived tumors.
Cancer & Metabolism, September 23, 2021, 33
eLife, September 09, 2025, 107536
Frontiers in Cellular and Infection Microbiology, October 08, 2025, 1648576
S1733 Methylprednisolone Methylprednisolone is a synthetic glucocorticoid receptor agonist, used to achieve prompt suppression of inflammation. This compound activates ACE2 and reduces IL-6 levels, thus improves severe or critical COVID-19. It markedly reduces autophagy and apoptosis.
iScience, 2025, 114293
Food Chem Toxicol, 2024, 188:114665
Clinical Cancer Research, 2022, 4444-4455
Verified customer review of Methylprednisolone
S6912 Vacuolin-1 Vacuolin-1 is a potent and cell-permeable inhibitor that blocks the Ca(2+)-dependent exocytosis of lysosomes and prevents the release of lysosomal content without affecting the process of resealing. This compound is also a potent and selective PIKfyve inhibitor, and inhibits autophagy by impairing lysosomal maturation via PIKfyve inhibition.
Autophagy, 2025, 1-15.
Virulence, 2024, 15(1):2350893
Virulence, 2024, 2350893
S3758 Sinomenine hydrochloride Sinomenine (SN, Cucoline, Kukoline, Sabianine A), extracted from the Chinese medicinal plant, sinomenium acutum, is a potent anti-inflammatory and neuroprotective agent.
Biomed Res Int, 2022, 2022:4914005
Cancer Manag Res, 2021, 13:1189-1204
Bioorg Med Chem, 2020, 31:115986
S5973 Methylprednisolone Acetate Methylprednisolone (NSC-19987, Medrol) acetate is a synthetic glucocorticoid receptor agonist, used to achieve prompt suppression of inflammation. Methylprednisolone activates ACE2 and reduces IL-6 levels, thus improves severe or critical COVID-19. Methylprednisolone markedly reduces autophagy and apoptosis.
Current Issues in Molecular Biology, 2022, 1046-1061
S4643 KB-R7943 mesylate KB-R7943 mesylate is a widely used inhibitor of the reverse Na+/Ca2+ exchanger (NCX(rev)) with IC50 of 5.7 μM. This compound promotes prostate cancer cell death by activating the JNK pathway and blocking autophagic flux.
E1232 Concanavalin A Concanavalin A is a potential anti-neoplastic agent targeting apoptosis, autophagy and anti-angiogenesis for cancer therapeutics.